Examedi
Examedi is a Chilean digital health platform founded in 2021 that delivers at-home blood tests, telemedicine, vaccinations, and automatic ISAPRE reimbursement to individual patients and corporate clients across Chile and Mexico.
- Company typePrivate
- Founded2021
- HeadquartersLas Condes, Chile
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Examedi does
Examedi is a Chilean digital health company founded in 2021 that operates an at-home healthcare services platform connecting patients to certified healthcare professionals for blood draws, laboratory testing, telemedicine consultations, and vaccinations. The platform serves individual consumers across Chile's Santiago Metropolitan Region (35 communes), Valparaíso, and Coquimbo, and has expanded into Mexico. Core products include Exámenes a Domicilio (at-home sample collection), Telemedicina (24/7 video consultations across general medicine and specialties), at-home vaccination (including the 2026 influenza campaign), medical order upload with automated quotation, and a biomarker dashboard tracking 100+ health indicators.
The underlying technology combines a self-serve booking and scheduling platform with integrations into Chile's healthcare reimbursement infrastructure: direct connections to all major ISAPREs (Colmena, Banmedica, Consalud, Cruz Blanca, Vida Tres), FONASA bonus processing, and a fintech partnership with Gokei for automatic one-click digital reimbursement. The company has developed a public price comparison tool benchmarking its exam pricing against traditional Chilean health centers, alongside a recently launched mobile application.
Examedi operates a hybrid B2C/B2B revenue model. Consumer revenue is generated per-test or per-consultation, with prices ranging from roughly $4,980 CLP for individual exams to over $421,200 CLP for comprehensive packs, and telemedicine starting at $25,000 CLP. The B2B motion targets corporate clients including Uber, Copec, Scotiabank, BancoEstado, LATAM, Pfizer, BUK, Fintual, and Chubb for employee wellness programs and on-site campaigns. Distribution combines self-serve online booking, WhatsApp-based customer support, healthcare provider partnerships (Clínica Alemana, Nueva Masvida via Imalab), and insurance-channel reselling (Caja Los Andes). The company is Y Combinator alumni (2021), closed a $17 million Series A led by General Catalyst in June 2022, and has cumulatively served more than 300,000 patients.
Examedi firmographics
Firmographics- Name
- Examedi
- Legal name
- Examedi
- Website
- https://examedi.cl
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Examedi is a Chilean digital health platform founded in 2021 that delivers at-home blood tests, telemedicine, vaccinations, and automatic ISAPRE reimbursement to individual patients and corporate clients across Chile and Mexico.
- Ownership category
- akta.pro rank
Examedi industry classification
Industry- Product category
- At-Home Healthcare Services
- NAICS
- Medical Laboratories (621511), Home Health Care Services (62161), Offices of Physicians (6211)
- SIC
- Services-Medical Laboratories (8071), Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)
- akta.pro secondary industries
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), Urgent Care + ePrescribing & Lab/Imaging Ordering Telehealth Platforms (HLALAJAL)
Keywords
Where Examedi is headquartered
LocationHeadquarters
- HQ city
- Las Condes
- HQ country
- Chile
- HQ region
- Latin America
Offices2 records
Markets served
Examedi business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- At-Home Diagnostic Testing: Individual patients and corporate clients pay per examination or examination pack for at-home blood draws and laboratory tests. Prices range from approximately $4,980 CLP for basic tests like hemogram to over $421,200 CLP for comprehensive packs. The service is reimbursable by ISAPRE and bonifiable by FONASA, making it attractive to patients.
- Telemedicine Consultations: Patients pay per telemedicine consultation starting from $25,000 CLP for general medicine. Consultations are bonificable with FONASA and reimbursable with ISAPRE and supplementary health insurance. Specialties offered include general medicine, psychiatry, psychology, dermatology, neurology, and child psychology.
- Vaccination Services: Revenue from at-home vaccination services including influenza vaccines. Influenza vaccine 2026 starts from $16,890 CLP per person, with special pricing through partner insurers like Caja los Andes ($6,100 CLP per person for affiliated members). Additional services include Neurobion packages and other injectables.
- Corporate/Enterprise Health Services: B2B revenue stream providing employee health programs, on-site examination campaigns, and corporate vaccination programs. Enterprise clients displayed include Uber, Copec, Scotiabank, BancoEstado, BUK, and others, suggesting dedicated corporate sales engagement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | General Medicine Telemedicine Consultation |
| Unit Pricing | Pay-as-you-go | Specialist Telemedicine Consultations |
| Unit Pricing | Pay-as-you-go | Influenza Vaccine 2026 |
| Unit Pricing | Pay-as-you-go | Blood Examination Packs |
| Freemium | Pay-as-you-go | Medical Order Upload and Quotation Service |
| Freemium | Pay-as-you-go | Price Comparison Engine |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels8 records
Examedi product offering
Product offeringCore offering
Examedi operates a digital healthcare platform that dispatches nurses and phlebotomists to patients' homes to collect samples for laboratory analysis, delivers those samples to partner labs, and returns results through a patient dashboard. The platform also provides 24/7 on-demand video telemedicine consultations with general practitioners and specialists, and offers at-home vaccination services with integrated automatic ISAPRE and FONASA insurance reimbursement.
Product overview
Examedi is a Chilean digital health platform offering a unified at-home healthcare services ecosystem. The core offerings are Exámenes a Domicilio (at-home blood and lab sample collection) and Telemedicina (24/7 online doctor consultations). These are complemented by vaccination at home, a medical order upload tool, an exam price comparison engine, a health blog, and a coverage checker. The platform integrates with Chilean health insurance systems for automatic reimbursement processing. Examedi serves individual patients and corporate clients (Examedi para Empresas) across the Santiago Metropolitan Region, Valparaíso, and Coquimbo in Chile.
Differentiator
Problem solved
Functional benefit
Products and services
- At-Home Blood and Laboratory Tests (Exámenes a Domicilio) On-demand at-home blood draws and laboratory sample collection for Chilean patients; a mobile nurse or phlebotomist visits the patient's home, transports samples to a partner lab, and results are returned through the Examedi patient dashboard with automatic ISAPRE/FONASA reimbursement processing.
- 24/7 Telemedicine Consultations (Telemedicina) On-demand video consultations with general practitioners and specialists available 24/7 through Examedi's platform, enabling Chilean patients to receive remote medical advice, prescriptions, and referrals without traveling to a clinic.
- At-Home Vaccination Service (Vacunación a Domicilio) At-home administration of vaccines by Examedi healthcare staff, including influenza and COVID-19 vaccines, distributed through compensation fund partners (e.g., Caja Los Andes) and direct consumer channels with automatic ISAPRE reimbursement.
Quantifiable outcome
- 300,000+ patients served since founding
- +5 more outcomes
Companies that use Examedi
Customer profileNamed customers19 records
Segments3 records
Ideal customer profiles2 records
Examedi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Examedi partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- GokeicoreStrategic fintech partnership with Gokei, a Chilean fintech specializing in reimbursement automation. The integration enables automatic digital processing of ISAPRE and supplementary health insurance reimbursements with a single click at checkout. The platform sends information directly to the patient's ISAPRE or insurer, managing the entire process digitally without forms, receipts, photos, or emails. Examedi is offering the first two management fees free for a limited time. This collaboration establishes a new standard in digital health in Chile.
- Nueva Masvida (via Imalab)coreStrategic alliance through Imalab laboratory benefiting over 400,000 Nueva Masvida affiliates. Examedi provides at-home diagnostic services to the insured member base, extending access to convenient healthcare while strengthening Nueva Masvida's digital health offerings.
- Clínica AlemanacoreStrategic partnership with Clínica Alemana, one of Chile's leading healthcare institutions, to reinforce digital strategy and at-home diagnostic services. Clínica Alemana endorsed Examedi as a digital health partner, leveraging Examedi's at-home testing capabilities to extend its digital health reach.
- ColmenacorePartnership with Colmena ISAPRE enabling automatic digital reimbursement processing for Colmena beneficiaries. Examedi's platform integrates directly with Colmena's systems for seamless reimbursement workflow, eliminating patient paperwork.
- BanmedicacorePartnership with Banmedica ISAPRE enabling automatic digital reimbursement processing for Banmedica beneficiaries through the Gokei-powered integration.
- ConsaludcorePartnership with Consalud ISAPRE enabling automatic digital reimbursement processing for Consalud beneficiaries through the integrated platform.
- Cruz BlancacorePartnership with Cruz Blanca ISAPRE enabling automatic digital reimbursement processing for Cruz Blanca beneficiaries through the integrated digital reimbursement platform.
- Vida TrescorePartnership with Vida Tres ISAPRE enabling automatic digital reimbursement processing for Vida Tres beneficiaries through the integrated platform.
- Caja Los AndescoreCorporate and distribution partnership with Caja Los Andes, a major Chilean health insurance fund. Caja Los Andes promotes Examedi's at-home influenza vaccination service to its affiliated members at discounted pricing ($6,100 CLP per person). Examedi appears as a preferred provider on Caja Los Andes' platform via sdk.examedi.com/cla-influenza-2026.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Examedi competitors and assessment
Company assessmentDirect peers
- Everlywell: US-based at-home lab testing platform offering direct-to-consumer diagnostics with physician-reviewed results and insurance integration. Highly comparable to Examedi's at-home blood draw and biomarker interpretation offering, with a similar marketplace-style model.
- LetsGetChecked: Global at-home diagnostics and telehealth company providing self-collected lab tests with nurse-led services and physician consultations. Closest direct comparable to Examedi's integrated at-home diagnostics + telemedicine + result delivery stack.
- Hilab: Brazilian healthtech offering rapid at-home and point-of-care laboratory testing with digital results delivery. Closest LATAM-region peer to Examedi in terms of at-home diagnostic service model and pricing transparency.
- Medismart: Chilean telemedicine and home-care healthtech operating in the same domestic market as Examedi. Comparable in providing remote consultations and home-based services to Chilean consumers and insurers, and competes for the same ISAPRE-integrated demand.
Broad incumbents
- Ro: US-based direct-to-patient telehealth and at-home diagnostics platform covering primary care, specialty care, and lab testing. Comparable integrated virtual-care-plus-diagnostics model; operates at significantly larger scale and broader service breadth than Examedi.
- Hims & Hers Health: Large US telehealth and consumer health company combining virtual consultations with at-home diagnostics, prescription delivery, and recurring wellness subscriptions. Broader portfolio than Examedi but operating the same integrated virtual-care-plus-at-home diagnostics thesis at much larger scale.
Others
- TytoCare: Provider of at-home telehealth examination devices and remote examination kits enabling clinicians to perform guided virtual exams. Adjacent enabling technology for home-based clinical services, complementary to Examedi's home-visit diagnostic and telemedicine offerings.
Emerging players
- dr.consulta: Brazilian outpatient healthcare marketplace offering consultations, exams, and procedures at transparent prices to consumers and corporates. Comparable in price-transparent, consumer-facing healthcare model targeting under-served middle-class demand, similar to Examedi's value proposition in Chile.
- Sami: Brazilian healthtech offering affordable employer-sponsored health plans with embedded telemedicine and digital care delivery. Comparable LATAM healthtech combining insurer/payer relationships, virtual care, and B2B2C distribution — similar GTM pattern to Examedi's corporate wellness motion.
- Labi Exames: Brazilian low-cost laboratory testing chain offering affordable blood work and diagnostic exams. Comparable in undercutting traditional lab pricing and offering a streamlined, consumer-friendly diagnostic experience — a similar value proposition in a larger adjacent LATAM market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Examedi social profiles
Digital presenceExamedi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Examedi leadership team
Management profileNumber of profiles
Profiles3 records
Examedi funding detail
Funding detailFunding overview
Funding rounds7 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Examedi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Examedi
What does Examedi do?
Examedi operates a digital healthcare platform that dispatches nurses and phlebotomists to patients' homes to collect samples for laboratory analysis, delivers those samples to partner labs, and returns results through a patient dashboard. The platform also provides 24/7 on-demand video telemedicine consultations with general practitioners and specialists, and offers at-home vaccination services with integrated automatic ISAPRE and FONASA insurance reimbursement.
Is Examedi a public or private company?
Examedi is a private company. It is classified as venture growth investor backed and is currently operating.
When was Examedi founded?
Examedi was founded in 2021. It employs 11 to 50 people.
Where is Examedi based?
Examedi is headquartered in Las Condes, Chile, in the Latin America region.
How does Examedi make money?
Four revenue lines are on record. At-Home Diagnostic Testing is the primary driver. The others are telemedicine Consultations, vaccination Services and corporate/Enterprise Health Services.
Who are Examedi's main competitors?
Direct peers on record are Everlywell, LetsGetChecked, Hilab and Medismart. Broad incumbents are Ro and Hims & Hers Health. TytoCare is listed as an others. Emerging players are dr.consulta, Sami and Labi Exames.
Does Examedi have an API?
No public API is recorded for Examedi.
What industry is Examedi in?
Examedi's product category is At-Home Healthcare Services. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care, with a secondary code of HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home). Its NAICS code is 621511 and its SIC code is 8071.